🟢 Milestone Pharmaceuticals is trading 5.66% up in pre-market with no clear overnight catalyst identified

Milestone Pharmaceuticals is trading 5.66% higher now at $1.16 after rising from the August 14, 2026 close of $1.10; no clear overnight catalyst has been identified.

• No new company-specific announcement or clear overnight catalyst was identified for August 17, 2026.
• The broader market is modestly positive, with the Nasdaq Composite up 0.51%, but that does not clearly explain the stock’s larger move.
• Recent earnings showed expanding CARDAMYST coverage but a wider-than-expected adjusted loss.